BD Q4 FY2024 revenue $5.4B (+6.9%), adjusted EPS $3.81 (+11.4%); issues FY25 EPS guidance $14.25-$14.60

BECTON DICKINSON & CO

2024-FY EPS reported $5.86 revenue$20,178,000,000

Q4 revenue $5.4B, +6.9% as reported; GAAP EPS $1.45 (vs $0.53), adjusted EPS $3.81 (vs $3.42).
FY24 revenue $20.2B, +4.2%; adjusted EPS $13.14 (+7.6%); free cash flow $3.1B (+47.4%).
FY25 guidance: organic revenue growth 4.0-4.5%; adjusted diluted EPS $14.25-$14.60 (midpoint ~10% growth).
Completed acquisition of Edwards Lifesciences' Critical Care product group, expanding smart connected care portfolio.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.